Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1998, p. 1207-1212, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Influence of Test Conditions on Antifungal
Time-Kill Curve Results: Proposal for Standardized Methods
Michael E.
Klepser,1,*
Erika J.
Ernst,1
Russell E.
Lewis,1
Michael E.
Ernst,1 and
Michael A.
Pfaller2
College of Pharmacy, The University of
Iowa,1 and
Department of
Pathology, The University of Iowa Hospitals and
Clinics,2 Iowa City, Iowa 52242
Received 5 January 1998/Returned for modification 4 February
1998/Accepted 9 March 1998
This study was designed to examine the effects of antifungal
carryover, agitation, and starting inoculum on the results of time-kill
tests conducted with various Candida species. Two isolates each of Candida albicans, Candida tropicalis,
and Candida glabrata were utilized. Test antifungal agents
included fluconazole, amphotericin B, and LY303366. Time-kill tests
were conducted in RPMI 1640 medium buffered with
morpholinepropanesulfonic acid (MOPS) to a pH of 7.0 and incubated at
35°C. Prior to testing, the existence of antifungal carryover was
evaluated at antifungal concentrations ranging from 1× to 16× MIC by
four plating methods: direct plating of 10, 30, and 100 µl of test
suspension and filtration of 30 µl of test suspension through a
0.45-µm-pore-size filter. Time-kill curves were performed with each
isolate at drug concentrations equal to 2× MIC, using a starting
inoculum of approximately 105 CFU/ml, and incubated with or
without agitation. Last, inoculum experiments were conducted over three
ranges of starting inocula: 5 × 102 to 1 × 104, >1 × 104 to 1 × 106, and >1 × 106 to 1 × 108 CFU/ml. Significant antifungal carryover (>25%
reduction in CFU/milliliter from the control value) was observed with
amphotericin B and fluconazole; however, carryover was eliminated with
filtration. Agitation did not appreciably affect results. The starting
inoculum did not significantly affect the activity of fluconazole or
amphotericin B; however, the activity of LY303366 may be influenced by
the starting inoculum. Before antifungal time-kill curve methods are routinely employed by investigators, methodology should be scrutinized and standardized procedures should be developed.
*
Corresponding author. Mailing address: The University
of Iowa College of Pharmacy, S412 Pharmacy Building, Iowa City,
IA 52242-1112. Phone: (319) 335-8861. Fax: (319) 353-5646. E-mail:
michael-klepser{at}uiowa.edu.
Antimicrobial Agents and Chemotherapy, May 1998, p. 1207-1212, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nguyen, K. T., Ta, P., Hoang, B. T., Cheng, S., Hao, B., Nguyen, M. H., Clancy, C. J.
(2009). Anidulafungin Is Fungicidal and Exerts a Variety of Postantifungal Effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates. Antimicrob. Agents Chemother.
53: 3347-3352
[Abstract]
[Full Text]
-
Varga, I., Soczo, G., Kardos, G., Majoros, L.
(2008). Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3. J Antimicrob Chemother
62: 149-152
[Abstract]
[Full Text]
-
Chaturvedi, V., Ramani, R., Ghannoum, M. A., Killian, S. B., Holliday, N., Knapp, C., Ostrosky-Zeichner, L., Messer, S. A., Pfaller, M. A., Iqbal, N. J., Arthington-Skaggs, B. A., Vazquez, J. A., Sein, T., Rex, J. H., Walsh, T. J.
(2008). Multilaboratory Testing of Antifungal Combinations against a Quality Control Isolate of Candida krusei. Antimicrob. Agents Chemother.
52: 1500-1502
[Abstract]
[Full Text]
-
Guo, Q., Sun, S., Yu, J., Li, Y., Cao, L.
(2008). Synergistic activity of azoles with amiodarone against clinically resistant Candida albicans tested by chequerboard and time-kill methods. J Med Microbiol
57: 457-462
[Abstract]
[Full Text]
-
Venisse, N., Gregoire, N., Marliat, M., Couet, W.
(2008). Mechanism-Based Pharmacokinetic-Pharmacodynamic Models of In Vitro Fungistatic and Fungicidal Effects against Candida albicans. Antimicrob. Agents Chemother.
52: 937-943
[Abstract]
[Full Text]
-
Li, Y., Sun, S., Guo, Q., Ma, L., Shi, C., Su, L., Li, H.
(2008). In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother
61: 577-585
[Abstract]
[Full Text]
-
Cota, J. M., Grabinski, J. L., Talbert, R. L., Burgess, D. S., Rogers, P. D., Edlind, T. D., Wiederhold, N. P.
(2008). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrob. Agents Chemother.
52: 1144-1146
[Abstract]
[Full Text]
-
Sun, S., Li, Y., Guo, Q., Shi, C., Yu, J., Ma, L.
(2008). In Vitro Interactions between Tacrolimus and Azoles against Candida albicans Determined by Different Methods. Antimicrob. Agents Chemother.
52: 409-417
[Abstract]
[Full Text]
-
Soczo, G., Kardos, G., Varga, I., Kelentey, B., Gesztelyi, R., Majoros, L.
(2007). In Vitro Study of Candida tropicalis Isolates Exhibiting Paradoxical Growth in the Presence of High Concentrations of Caspofungin. Antimicrob. Agents Chemother.
51: 4474-4476
[Abstract]
[Full Text]
-
Soczo, G., Kardos, G., McNicholas, P. M., Balogh, E., Gergely, L., Varga, I., Kelentey, B., Majoros, L.
(2007). Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species. J Antimicrob Chemother
60: 1004-1009
[Abstract]
[Full Text]
-
Cota, J., Carden, M., Graybill, J. R., Najvar, L. K., Burgess, D. S., Wiederhold, N. P.
(2006). In Vitro Pharmacodynamics of Anidulafungin and Caspofungin against Candida glabrata Isolates, Including Strains with Decreased Caspofungin Susceptibility. Antimicrob. Agents Chemother.
50: 3926-3928
[Abstract]
[Full Text]
-
Hasenoehrl, A., Galic, T., Ergovic, G., Marsic, N., Skerlev, M., Mittendorf, J., Geschke, U., Schmidt, A., Schoenfeld, W.
(2006). In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast Candida albicans.. Antimicrob. Agents Chemother.
50: 3011-3018
[Abstract]
[Full Text]
-
Clancy, C. J., Huang, H., Cheng, S., Derendorf, H., Nguyen, M. H.
(2006). Characterizing the Effects of Caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata Isolates by Simultaneous Time-Kill and Postantifungal-Effect Experiments.. Antimicrob. Agents Chemother.
50: 2569-2572
[Abstract]
[Full Text]
-
Lewis, R. E., Wiederhold, N. P., Prince, R. A., Kontoyiannis, D. P.
(2006). In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. J Antimicrob Chemother
57: 288-293
[Abstract]
[Full Text]
-
Petraitiene, R., Petraitis, V., Kelaher, A. M., Sarafandi, A. A., Mickiene, D., Groll, A. H., Sein, T., Bacher, J., Walsh, T. J.
(2005). Efficacy, Plasma Pharmacokinetics, and Safety of Icofungipen, an Inhibitor of Candida Isoleucyl-tRNA Synthetase, in Treatment of Experimental Disseminated Candidiasis in Persistently Neutropenic Rabbits. Antimicrob. Agents Chemother.
49: 2084-2092
[Abstract]
[Full Text]
-
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., Ghannoum, M. A.
(2005). Combination Treatment of Invasive Fungal Infections. Clin. Microbiol. Rev.
18: 163-194
[Abstract]
[Full Text]
-
Cuenca-Estrella, M.
(2004). Combinations of antifungal agents in therapy-what value are they?. J Antimicrob Chemother
54: 854-869
[Abstract]
[Full Text]
-
Canton, E., Peman, J., Gobernado, M., Viudes, A., Espinel-Ingroff, A.
(2004). Patterns of Amphotericin B Killing Kinetics against Seven Candida Species. Antimicrob. Agents Chemother.
48: 2477-2482
[Abstract]
[Full Text]
-
Pfaller, M. A., Sheehan, D. J., Rex, J. H.
(2004). Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization. Clin. Microbiol. Rev.
17: 268-280
[Abstract]
[Full Text]
-
Agarwal, A. K., Rogers, P. D., Baerson, S. R., Jacob, M. R., Barker, K. S., Cleary, J. D., Walker, L. A., Nagle, D. G., Clark, A. M.
(2003). Genome-wide Expression Profiling of the Response to Polyene, Pyrimidine, Azole, and Echinocandin Antifungal Agents in Saccharomyces cerevisiae. J. Biol. Chem.
278: 34998-35015
[Abstract]
[Full Text]
-
Rogers, P. D., Kramer, R. E., Crews, J. K., Lewis, R. E.
(2003). The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration. J Antimicrob Chemother
51: 305-312
[Abstract]
[Full Text]
-
Barchiesi, F., Milici, M. E., Arzeni, D., Schimizzi, A. M., Pizzo, G., Giammanco, G. M., Giannini, D., Manfrini, M., Scalise, G., Vicentini, C. B.
(2003). In vitro and in vivo anticryptococcal activities of a new pyrazolo-isothiazole derivative. J Antimicrob Chemother
51: 167-170
[Abstract]
[Full Text]
-
Ernst, E. J., Roling, E. E., Petzold, C. R., Keele, D. J., Klepser, M. E.
(2002). In Vitro Activity of Micafungin (FK-463) against Candida spp.: Microdilution, Time-Kill, and Postantifungal-Effect Studies. Antimicrob. Agents Chemother.
46: 3846-3853
[Abstract]
[Full Text]
-
Ripeau, J.-S., Aumont, F., Belhumeur, P., Ostrosky-Zeichner, L., Rex, J. H., de Repentigny, L.
(2002). Effect of the Echinocandin Caspofungin on Expression of Candida albicans Secretory Aspartyl Proteinases and Phospholipase In Vitro. Antimicrob. Agents Chemother.
46: 3096-3100
[Abstract]
[Full Text]
-
Lewis, R. E., Diekema, D. J., Messer, S. A., Pfaller, M. A., Klepser, M. E.
(2002). Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother
49: 345-351
[Abstract]
[Full Text]
-
Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W.
(2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev.
14: 643-658
[Abstract]
[Full Text]
-
Ostrosky-Zeichner, L., Bazemore, S., Paetznick, V. L., Rodriguez, J. R., Chen, E., Wallace, T., Cossum, P., Rex, J. H.
(2001). Differential Antifungal Activity of Isomeric Forms of Nystatin. Antimicrob. Agents Chemother.
45: 2781-2786
[Abstract]
[Full Text]
-
Klepser, M. E., Ernst, E. J., Petzold, C. R., Rhomberg, P., Doern, G. V.
(2001). Comparative Bactericidal Activities of Ciprofloxacin, Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin against Streptococcus pneumoniae in a Dynamic In Vitro Model. Antimicrob. Agents Chemother.
45: 673-678
[Abstract]
[Full Text]
-
Gunderson, S. M., Hoffman, H., Ernst, E. J., Pfaller, M. A., Klepser, M. E.
(2000). In Vitro Pharmacodynamic Characteristics of Nystatin Including Time-Kill and Postantifungal Effect. Antimicrob. Agents Chemother.
44: 2887-2890
[Abstract]
[Full Text]
-
Klepser, M. E., Malone, D., Lewis, R. E., Ernst, E. J., Pfaller, M. A.
(2000). Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology. Antimicrob. Agents Chemother.
44: 1917-1920
[Abstract]
[Full Text]
-
Ernst, E. J., Klepser, M. E., Pfaller, M. A.
(2000). Postantifungal Effects of Echinocandin, Azole, and Polyene Antifungal Agents against Candida albicans and Cryptococcus neoformans. Antimicrob. Agents Chemother.
44: 1108-1111
[Abstract]
[Full Text]